Integrating a Gender Lens into Uganda’s Advocacy and Demand Generation Plan for COVID-19 Vaccines

LOOK AT THIS IF YOU'RE INTERESTED IN:

Learning about Uganda’s integration of gender evidence into the country’s Advocacy and Demand Generation strategy.

HOW YOU CAN USE THIS MATERIAL:

Public health leaders can leverage the insights gained from Uganda’s initiative to integrate a gender lens in guiding ongoing immunisation efforts around COVID-19.

OVERVIEW:

While Uganda has made significant progress in increasing access to immunisation in recent years, vaccine inequity remains a challenge. The COVID-19 pandemic has further disrupted immunisation efforts and disproportionately affected women and children in communities where vaccine coverage was already low. The PATH Uganda team supported the Ugandan government in the development of an advocacy and demand generation handbook with a gender lens to address the inequitable distribution of immunisations among women and girls. This case study summarizes the strategy and outlines the challenges and enabling factors.

You May Also Like

Scoping Review of Current Costing Literature on Interventions to Reach Zero-Dose Children in Low- and Middle-Income Countries

A study in Vaccines analyzes the costs and effectiveness of interventions aimed at reaching zero-dose children—those who have not received any routine vaccinations—in low- and middle-income countries (LMICs). The research evaluates strategies such as mobile outreach, community engagement, and health system strengthening, highlighting their cost-effectiveness in improving immunisation coverage. The findings suggest that tailored, context-specific … Read More

Read

Socioeconomic-related inequities in child immunisation: horizontal and vertical dimensions for policy insights

A study in Health Economics Review investigates the economic and equity impacts of expanding immunisation programs in low- and middle-income countries (LMICs), focusing on the cost-effectiveness of introducing new vaccines. The research highlights that while scaling up immunisation efforts requires significant investment, the long-term benefits—such as reduced disease burden, healthcare savings, and improved productivity—justify the … Read More

Read